Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$43.08 n/a | n/a%
02/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 172.59M 1.09M 1.69M 1.87M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 172.59M 1.09M 1.69M 1.87M
Selling, General, and Administrative Expenses 19.33M 9.52M 7.11M 5.68M
Research & Development 35.69M 22.71M 17.84M 14.26M
Operating Income before D & A (EBITDA) 117.57M -31.14M -23.26M -18.06M
Depreciation & Amortization n.a. 891.00K 788.00K 687.00K
Interest Income n.a. 12.00K 14.00K 11.00K
Other Income - Net 60.00K 112.00K -38.00K 5.00K
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 117.63M -31.91M -24.07M -18.73M
Interest Expense 0.00 33.00K 38.00K 42.00K
Pre-Tax Income 117.63M -31.94M -24.11M -18.78M
Income Taxes 14.78M 130.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 -1.00K
Net Income From Continuing Operations 102.86M -31.18M -23.32M -18.09M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 102.86M -31.18M -23.32M -18.09M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 102.86M -31.18M -23.32M -18.09M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -31.18M -23.32M -18.09M
Preferred Dividends
Net Income Available To Common 0.00 -31.18M -23.32M -18.09M
Basic EPS from Continuing Ops. 3.69 -1.23 -1.12 -2.98
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.69 -1.23 -1.12 -2.98
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.69 -1.23 -1.12 -2.98
Basic Normalized Net Income/Share n.a. -1.23 -1.12 -2.98
EPS fr Continuing Ops. 3.32 -1.23 -1.12 -2.98
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.32 -1.23 -1.12 -2.98
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.32 -1.23 -1.12 -2.98
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -1.23 -1.12 -2.98
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter